4-(6-chloropyrimidin-4-yl)morpholine;ethyl 8-bromo-2-phenylimidazo[1,2-a]pyridine-3-carboxylate;ethyl 8-(6-morpholin-4-ylpyrimidin-4-yl)-2-phenylimidazo[1,2-a]pyridine-3-carboxylate;ethyl 2-phenyl-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)imidazo[1,2-a]pyridine-3-carboxylate;8-(6-morpholin-4-ylpyrimidin-4-yl)-2-phenylimidazo[1,2-a]pyridine-3-carboxylic acid

C92H90BBrClN17O13 — CID 159710680

IUPAC4-(6-chloropyrimidin-4-yl)morpholine;ethyl 8-bromo-2-phenylimidazo[1,2-a]pyridine-3-carboxylate;ethyl 8-(6-morpholin-4-ylpyrimidin-4-yl)-2-phenylimidazo[1,2-a]pyridine-3-carboxylate;ethyl 2-phenyl-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)imidazo[1,2-a]pyridine-3-carboxylate;8-(6-morpholin-4-ylpyrimidin-4-yl)-2-phenylimidazo[1,2-a]pyridine-3-carboxylic acid
SMILESCCOC(=O)c1c(-c2ccccc2)nc2c(-c3cc(N4CCOCC4)ncn3)cccn12.CCOC(=O)c1c(-c2ccccc2)nc2c(B3OC(C)(C)C(C)(C)O3)cccn12.CCOC(=O)c1c(-c2ccccc2)nc2c(Br)cccn12.Clc1cc(N2CCOCC2)ncn1.O=C(O)c1c(-c2ccccc2)nc2c(-c3cc(N4CCOCC4)ncn3)cccn12
InChIInChI=1S/C24H23N5O3.C22H25BN2O4.C22H19N5O3.C16H13BrN2O2.C8H10ClN3O/c1-2-32-24(30)22-21(17-7-4-3-5-8-17)27-23-18(9-6-10-29(22)23)19-15-20(26-16-25-19)28-11-13-31-14-12-28;1-6-27-20(26)18-17(15-11-8-7-9-12-15)24-19-16(13-10-14-25(18)19)23-28-21(2,3)22(4,5)29-23;28-22(29)20-19(15-5-2-1-3-6-15)25-21-16(7-4-8-27(20)21)17-13-18(24-14-23-17)26-9-11-30-12-10-26;1-2-21-16(20)14-13(11-7-4-3-5-8-11)18-15-12(17)9-6-10-19(14)15;9-7-5-8(11-6-10-7)12-1-3-13-4-2-12/h3-10,15-16H,2,11-14H2,1H3;7-14H,6H2,1-5H3;1-8,13-14H,9-12H2,(H,28,29);3-10H,2H2,1H3;5-6H,1-4H2
InChIKeyMYUIOKLIYRRHKG-UHFFFAOYSA-N
MW1768.01 g/mol
LogP14.85
Rot. Bonds17

About 4-(6-chloropyrimidin-4-yl)morpholine;ethyl 8-bromo-2-phenylimidazo[1,2-a]pyridine-3-carboxylate;ethyl 8-(6-morpholin-4-ylpyrimidin-4-yl)-2-phenylimidazo[1,2-a]pyridine-3-carboxylate;ethyl 2-phenyl-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)imidazo[1,2-a]pyridine-3-carboxylate;8-(6-morpholin-4-ylpyrimidin-4-yl)-2-phenylimidazo[1,2-a]pyridine-3-carboxylic acid

4-(6-chloropyrimidin-4-yl)morpholine;ethyl 8-bromo-2-phenylimidazo[1,2-a]pyridine-3-carboxylate;ethyl 8-(6-morpholin-4-ylpyrimidin-4-yl)-2-phenylimidazo[1,2-a]pyridine-3-carboxylate;ethyl 2-phenyl-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)imidazo[1,2-a]pyridine-3-carboxylate;8-(6-morpholin-4-ylpyrimidin-4-yl)-2-phenylimidazo[1,2-a]pyridine-3-carboxylic acid (PubChem CID 159710680) has the molecular formula C92H90BBrClN17O13 and a molecular weight of 1768.01 g/mol. Its IUPAC name is 4-(6-chloropyrimidin-4-yl)morpholine;ethyl 8-bromo-2-phenylimidazo[1,2-a]pyridine-3-carboxylate;ethyl 8-(6-morpholin-4-ylpyrimidin-4-yl)-2-phenylimidazo[1,2-a]pyridine-3-carboxylate;ethyl 2-phenyl-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)imidazo[1,2-a]pyridine-3-carboxylate;8-(6-morpholin-4-ylpyrimidin-4-yl)-2-phenylimidazo[1,2-a]pyridine-3-carboxylic acid.

Molecular Properties

Compound Name4-(6-chloropyrimidin-4-yl)morpholine;ethyl 8-bromo-2-phenylimidazo[1,2-a]pyridine-3-carboxylate;ethyl 8-(6-morpholin-4-ylpyrimidin-4-yl)-2-phenylimidazo[1,2-a]pyridine-3-carboxylate;ethyl 2-phenyl-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)imidazo[1,2-a]pyridine-3-carboxylate;8-(6-morpholin-4-ylpyrimidin-4-yl)-2-phenylimidazo[1,2-a]pyridine-3-carboxylic acid
PubChem CID159710680
Molecular FormulaC92H90BBrClN17O13
Molecular Weight1768.01 g/mol
Exact Mass1765.59
IUPAC Name4-(6-chloropyrimidin-4-yl)morpholine;ethyl 8-bromo-2-phenylimidazo[1,2-a]pyridine-3-carboxylate;ethyl 8-(6-morpholin-4-ylpyrimidin-4-yl)-2-phenylimidazo[1,2-a]pyridine-3-carboxylate;ethyl 2-phenyl-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)imidazo[1,2-a]pyridine-3-carboxylate;8-(6-morpholin-4-ylpyrimidin-4-yl)-2-phenylimidazo[1,2-a]pyridine-3-carboxylic acid
SMILESCCOC(=O)c1c(-c2ccccc2)nc2c(-c3cc(N4CCOCC4)ncn3)cccn12.CCOC(=O)c1c(-c2ccccc2)nc2c(B3OC(C)(C)C(C)(C)O3)cccn12.CCOC(=O)c1c(-c2ccccc2)nc2c(Br)cccn12.Clc1cc(N2CCOCC2)ncn1.O=C(O)c1c(-c2ccccc2)nc2c(-c3cc(N4CCOCC4)ncn3)cccn12
InChIInChI=1S/C24H23N5O3.C22H25BN2O4.C22H19N5O3.C16H13BrN2O2.C8H10ClN3O/c1-2-32-24(30)22-21(17-7-4-3-5-8-17)27-23-18(9-6-10-29(22)23)19-15-20(26-16-25-19)28-11-13-31-14-12-28;1-6-27-20(26)18-17(15-11-8-7-9-12-15)24-19-16(13-10-14-25(18)19)23-28-21(2,3)22(4,5)29-23;28-22(29)20-19(15-5-2-1-3-6-15)25-21-16(7-4-8-27(20)21)17-13-18(24-14-23-17)26-9-11-30-12-10-26;1-2-21-16(20)14-13(11-7-4-3-5-8-11)18-15-12(17)9-6-10-19(14)15;9-7-5-8(11-6-10-7)12-1-3-13-4-2-12/h3-10,15-16H,2,11-14H2,1H3;7-14H,6H2,1-5H3;1-8,13-14H,9-12H2,(H,28,29);3-10H,2H2,1H3;5-6H,1-4H2
InChIKeyMYUIOKLIYRRHKG-UHFFFAOYSA-N
XLogP14.85
TPSA318.61 Ų
H-Bond Donors1
H-Bond Acceptors29
Rotatable Bonds17
Heavy Atoms125
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001768.01
LogP ≤ 514.85
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 1029

Computed Properties (RDKit)

Structural Alerts{'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'}

Analyze 4-(6-chloropyrimidin-4-yl)morpholine;ethyl 8-bromo-2-phenylimidazo[1,2-a]pyridine-3-carboxylate;ethyl 8-(6-morpholin-4-ylpyrimidin-4-yl)-2-phenylimidazo[1,2-a]pyridine-3-carboxylate;ethyl 2-phenyl-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)imidazo[1,2-a]pyridine-3-carboxylate;8-(6-morpholin-4-ylpyrimidin-4-yl)-2-phenylimidazo[1,2-a]pyridine-3-carboxylic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4-(6-chloropyrimidin-4-yl)morpholine;ethyl 8-bromo-2-phenylimidazo[1,2-a]pyridine-3-carboxylate;ethyl 8-(6-morpholin-4-ylpyrimidin-4-yl)-2-phenylimidazo[1,2-a]pyridine-3-carboxylate;ethyl 2-phenyl-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)imidazo[1,2-a]pyridine-3-carboxylate;8-(6-morpholin-4-ylpyrimidin-4-yl)-2-phenylimidazo[1,2-a]pyridine-3-carboxylic acid?
The IUPAC name of 4-(6-chloropyrimidin-4-yl)morpholine;ethyl 8-bromo-2-phenylimidazo[1,2-a]pyridine-3-carboxylate;ethyl 8-(6-morpholin-4-ylpyrimidin-4-yl)-2-phenylimidazo[1,2-a]pyridine-3-carboxylate;ethyl 2-phenyl-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)imidazo[1,2-a]pyridine-3-carboxylate;8-(6-morpholin-4-ylpyrimidin-4-yl)-2-phenylimidazo[1,2-a]pyridine-3-carboxylic acid (CID 159710680) is 4-(6-chloropyrimidin-4-yl)morpholine;ethyl 8-bromo-2-phenylimidazo[1,2-a]pyridine-3-carboxylate;ethyl 8-(6-morpholin-4-ylpyrimidin-4-yl)-2-phenylimidazo[1,2-a]pyridine-3-carboxylate;ethyl 2-phenyl-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)imidazo[1,2-a]pyridine-3-carboxylate;8-(6-morpholin-4-ylpyrimidin-4-yl)-2-phenylimidazo[1,2-a]pyridine-3-carboxylic acid.
What is the SMILES notation for 4-(6-chloropyrimidin-4-yl)morpholine;ethyl 8-bromo-2-phenylimidazo[1,2-a]pyridine-3-carboxylate;ethyl 8-(6-morpholin-4-ylpyrimidin-4-yl)-2-phenylimidazo[1,2-a]pyridine-3-carboxylate;ethyl 2-phenyl-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)imidazo[1,2-a]pyridine-3-carboxylate;8-(6-morpholin-4-ylpyrimidin-4-yl)-2-phenylimidazo[1,2-a]pyridine-3-carboxylic acid?
The canonical SMILES for 4-(6-chloropyrimidin-4-yl)morpholine;ethyl 8-bromo-2-phenylimidazo[1,2-a]pyridine-3-carboxylate;ethyl 8-(6-morpholin-4-ylpyrimidin-4-yl)-2-phenylimidazo[1,2-a]pyridine-3-carboxylate;ethyl 2-phenyl-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)imidazo[1,2-a]pyridine-3-carboxylate;8-(6-morpholin-4-ylpyrimidin-4-yl)-2-phenylimidazo[1,2-a]pyridine-3-carboxylic acid is CCOC(=O)c1c(-c2ccccc2)nc2c(-c3cc(N4CCOCC4)ncn3)cccn12.CCOC(=O)c1c(-c2ccccc2)nc2c(B3OC(C)(C)C(C)(C)O3)cccn12.CCOC(=O)c1c(-c2ccccc2)nc2c(Br)cccn12.Clc1cc(N2CCOCC2)ncn1.O=C(O)c1c(-c2ccccc2)nc2c(-c3cc(N4CCOCC4)ncn3)cccn12.
What is the InChIKey of 4-(6-chloropyrimidin-4-yl)morpholine;ethyl 8-bromo-2-phenylimidazo[1,2-a]pyridine-3-carboxylate;ethyl 8-(6-morpholin-4-ylpyrimidin-4-yl)-2-phenylimidazo[1,2-a]pyridine-3-carboxylate;ethyl 2-phenyl-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)imidazo[1,2-a]pyridine-3-carboxylate;8-(6-morpholin-4-ylpyrimidin-4-yl)-2-phenylimidazo[1,2-a]pyridine-3-carboxylic acid?
The InChIKey is MYUIOKLIYRRHKG-UHFFFAOYSA-N. The full InChI is InChI=1S/C24H23N5O3.C22H25BN2O4.C22H19N5O3.C16H13BrN2O2.C8H10ClN3O/c1-2-32-24(30)22-21(17-7-4-3-5-8-17)27-23-18(9-6-10-29(22)23)19-15-20(26-16-25-19)28-11-13-31-14-12-28;1-6-27-20(26)18-17(15-11-8-7-9-12-15)24-19-16(13-10-14-25(18)19)23-28-21(2,3)22(4,5)29-23;28-22(29)20-19(15-5-2-1-3-6-15)25-21-16(7-4-8-27(20)21)17-13-18(24-14-23-17)26-9-11-30-12-10-26;1-2-21-16(20)14-13(11-7-4-3-5-8-11)18-15-12(17)9-6-10-19(14)15;9-7-5-8(11-6-10-7)12-1-3-13-4-2-12/h3-10,15-16H,2,11-14H2,1H3;7-14H,6H2,1-5H3;1-8,13-14H,9-12H2,(H,28,29);3-10H,2H2,1H3;5-6H,1-4H2.
What are the key properties of 4-(6-chloropyrimidin-4-yl)morpholine;ethyl 8-bromo-2-phenylimidazo[1,2-a]pyridine-3-carboxylate;ethyl 8-(6-morpholin-4-ylpyrimidin-4-yl)-2-phenylimidazo[1,2-a]pyridine-3-carboxylate;ethyl 2-phenyl-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)imidazo[1,2-a]pyridine-3-carboxylate;8-(6-morpholin-4-ylpyrimidin-4-yl)-2-phenylimidazo[1,2-a]pyridine-3-carboxylic acid?
4-(6-chloropyrimidin-4-yl)morpholine;ethyl 8-bromo-2-phenylimidazo[1,2-a]pyridine-3-carboxylate;ethyl 8-(6-morpholin-4-ylpyrimidin-4-yl)-2-phenylimidazo[1,2-a]pyridine-3-carboxylate;ethyl 2-phenyl-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)imidazo[1,2-a]pyridine-3-carboxylate;8-(6-morpholin-4-ylpyrimidin-4-yl)-2-phenylimidazo[1,2-a]pyridine-3-carboxylic acid has a molecular weight of 1768.01 g/mol, XLogP of 14.85, 17 rotatable bonds, 1 hydrogen bond donors, and 29 hydrogen bond acceptors.
Where does this data come from?
All data for 4-(6-chloropyrimidin-4-yl)morpholine;ethyl 8-bromo-2-phenylimidazo[1,2-a]pyridine-3-carboxylate;ethyl 8-(6-morpholin-4-ylpyrimidin-4-yl)-2-phenylimidazo[1,2-a]pyridine-3-carboxylate;ethyl 2-phenyl-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)imidazo[1,2-a]pyridine-3-carboxylate;8-(6-morpholin-4-ylpyrimidin-4-yl)-2-phenylimidazo[1,2-a]pyridine-3-carboxylic acid is sourced from PubChem (CID 159710680), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).